Gynaecology
Prophylaxis - Surgical Guidelines
Type of surgery Is surgical Prophylactic Penicillin Severe
prophylaxis antibiotic alergy hypersensitivity
required? of choice to penicillins
|
SKIN |
|||||
|
Skin grafting |
Ö |
Should be considered |
Co-amoxiclav |
Cefuroxime |
Clindamycin
|
|
Consider addition of Teicoplanin if MRSA high risk/known colonisation |
|||||
|
LIMB SURGERY |
|||||
|
Lower limb amputation |
A |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin + Gentamicin
|
|
Vascular surgery (abdominal and lower limb arterial reconstruction) |
A |
Recommended
|
Co-amoxiclav |
Cefuroxime + Metronidazole |
Teicoplanin + Gentamicin + Metronidazole
|
|
Varicose veins |
|
Should be considered in patients undergoing groin surgery* |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Teicoplanin + Gentamicin + Metronidazole |
|
Soft tissue surgery of the hand |
Ö |
Should be considered |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin
|
|
*A recent study concluded that prophylactic antibiotics are beneficial in patients undergoing groin surgery for varicose veins especially if patients are obese or are current smokers. (8) Consider addition of Teicoplanin if MRSA high risk/known colonisation |
|||||
|
UROGENITAL SURGERY |
|||||
|
Circumcision (routine elective) |
Ö |
Not recommended |
|
|
|
|
Hydrocoeles |
C |
Not recommended |
|
|
|
|
Urethral catheterization |
|
Should be considered ** |
Gentamicin stat dose as per renal function and wt |
Gentamicin stat dose as per renal function and weight |
Gentamicin stat dose as per renal function and weight |
|
TURP |
A |
Recommended |
Gentamicin + Amoxicillin |
Gentamicin |
Gentamicin |
|
**The Irish “Guidelines for the Prevention of Catheter-associated Urinary Tract Infection” states that “There is no role for routine antimicrobial prophylaxis in patients with urinary catheters” and “Possible benefits of prophylaxis must be balanced against possible adverse effects.” However, “pending further evidence it seems reasonable to recommend a single dose of appropriate antimicrobial prophylaxis in a select group of high-risk patients” i.e. patients with bacteriuria at high risk of endocarditis or who are significantly immunocompromised (e.g. patients with neutropenia, haematological malignancy, post solid organ transplant). (21) Consider addition of Teicoplanin if MRSA high risk/known colonisation |
|||||
|
UPPER GASTROINTESTINAL |
|||||
|
Oesophageal surgery |
D |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Stomach & duodenal surgery |
A |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Gastric bypass surgery |
D |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Small intestine surgery |
D |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Consider addition of Teicoplanin if MRSA high risk/known colonisation |
|||||
|
HEPATOBILIARY |
|||||
|
Bile duct surgery |
A |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Pancreatic surgery |
B |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Liver surgery |
B |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Gall bladder surgery (open) |
A |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Gall bladder surgery (laparoscopic) |
A Ö |
Not recommended Should be considered in high risk*** patients |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
***High risk: intraoperative cholangiogram, bile spillage, conversion to laparotomy, acute cholecystitis/pancreatitis, jaundice, pregnancy, immunosuppression, insertion of prosthetic devices, extremes of age, diabetes, obesity, poor nutritional state, known co-existing bacterial colonization / infections at other sites. Consider addition of Teicoplanin if MRSA high risk/known colonization |
|||||
|
LOWER GASTROINTESTINAL |
|||||
|
Appendicectomy |
A |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Colorectal surgery (incl. laparoscopic) |
A |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Haemorrhoidectomies |
|
Should be considered |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Consider addition of Teicoplanin if MRSA high risk/known colonisation. |
|||||
|
ABDOMEN |
|||||
|
Hernia repair – groin (Inguinal/femoral OR Laparoscopic with or without mesh) |
A |
Should be considered* |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin |
|
Hernia repair (incisional with or without mesh) |
C |
Should be considered* |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin
|
|
Diagnostic endoscopic procedures |
D |
Not recommended |
|
|
|
|
Therapeutic endoscopic procedures (ERCP and PEG) |
D |
Should be considered in high risk# patients |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
*Benefits of prophylaxis for clean surgical procedures is not clear. One analysis of inguinal hernia repair found prophylaxis to be beneficial in repairs with mesh9 while another analysis concluded that the data was not sufficiently strong to make firm recommendations for or against their use universally10 #High risk: intraoperative cholangiogram, bile spillage, conversion to laparotomy, acute cholecystitis/pancreatitis, jaundice, pregnancy, immunosuppression, insertion of prosthetic devices, extremes of age, diabetes, obesity, poor nutritional state, known co-existing bacterial colonization / infections at other sites. Consider addition of Teicoplanin if MRSA high risk/known colonisation |
|||||
|
SPLEEN (NOTE: Please refer to Appendix 1 of long version of guidelines for post-splenectomy recommendations) |
|||||
|
Splenectomy |
Ö |
Not recommended Should be considered in high risk*patients |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin + Gentamicin |
|
|||||
|
GYNAECOLOGICAL SURGERY |
|
||||
|
Abdominal hysterectomy |
A |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Vaginal hysterectomy |
A |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Gentamicin + Metronidazole |
|
Caesarean section |
A |
Highly recommended |
Co-amoxiclav |
Cefuroxime |
Clindamycin |
|
Assisted delivery |
A |
Not recommended |
|
|
|
|
Perineal tear |
D |
Recommended for 3rd/4th degree perineal tears involving the anal sphincter/rectal mucosa |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin + Gentamicin |
|
Manual removal of the placenta |
D |
Should be considered Recommended in proven chlamydia or gonorrhoea infection |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin + Gentamicin |
|
Evacuation of incomplete miscarriage |
A |
Not recommended |
|
|
|
|
Intrauterine contraceptive device (IUCD) insertion |
A |
Not recommended – consider if known colonisation |
|
|
|
|
Consider addition of Teicoplanin if MRSA high risk/known colonisation. |
|||||
|
EAR, NOSE & THROAT SURGERY |
|||||
|
Ear Surgery |
A |
Not recommended |
|
|
|
|
Routine nose, sinus and endoscopic sinus surgery |
A |
Not recommended |
|
|
|
|
Complex septoplasty |
A |
Recommended |
Co-amoxiclav |
Cefuroxime |
Clindamycin |
|
Tonsillectomy |
Ö |
Not recommended |
|
|
|
|
Grommet insertion |
B |
A single dose of topical antibiotic isrecommended |
|
|
|
|
Adenoidectomy |
A |
Not recommended |
|
|
|
|
Thyroid lobectomy |
|
Should be considered |
Co-amoxiclav |
Cefuroxime |
Clindamycin
|
|
Consider addition of Teicoplanin if MRSA high risk/known colonization
|
|||||
|
HEAD AND NECK SURGERY |
|||||
|
HEAD and neck surgery (clean, benign |
D |
Antibiotic prophylaxis is not recommended |
|
|
|
|
Head and neck surgery (clean, malignant; neck dissection) |
C |
Antibiotic prophylaxis should be considered |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin |
|
Head and neck surgery (contaminated/clean-contaminated) |
A |
Antibiotic prophylaxis isrecommended* |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Clindamycin |
|
*Antibiotic prophylaxis should be considered in head and neck surgery that is clean, malignant or includes neck dissection.
The duration of prophylactic antibiotics should not be more than 24 hours
Consider addition of Teicoplanin if MRSA high risk/known colonization |
|||||
|
NON-OPERATIVE INTERVENTIONS |
|||||
|
Intravascular catheter insertion (Non-tunnelled & Tunnelled CVC) |
D
A |
Not recommended (14) |
|
|
|
|
GENERAL (where procedure does not fit in categories above) |
|||||
|
Clean-contaminated procedures |
D |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Please discuss with Microbiology team. |
|
Insertion of a prosthetic device or implant |
D |
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Please discuss with Microbiology team. |
|
Dirty or infected procedures
|
|
Recommended |
Co-amoxiclav |
Cefuroxime + Metronidazole |
Please discuss with Microbiology team. |
|
Consider addition of Teicoplanin if MRSA high risk/known colonization |
|||||
Please note this is a condensed version of these guidelines to facilitate display.
For full guideline and references please see full version of guidelines available on WGH Published Information Folder.
